Michael Simons

47.7k total citations · 9 hit papers
432 papers, 34.6k citations indexed

About

Michael Simons is a scholar working on Molecular Biology, Surgery and Cell Biology. According to data from OpenAlex, Michael Simons has authored 432 papers receiving a total of 34.6k indexed citations (citations by other indexed papers that have themselves been cited), including 253 papers in Molecular Biology, 82 papers in Surgery and 68 papers in Cell Biology. Recurrent topics in Michael Simons's work include Angiogenesis and VEGF in Cancer (125 papers), Coronary Interventions and Diagnostics (44 papers) and Fibroblast Growth Factor Research (40 papers). Michael Simons is often cited by papers focused on Angiogenesis and VEGF in Cancer (125 papers), Coronary Interventions and Diagnostics (44 papers) and Fibroblast Growth Factor Research (40 papers). Michael Simons collaborates with scholars based in United States, Germany and Israel. Michael Simons's co-authors include Sergey V. Buldyrev, Shlomo Havlin, Chung‐Kang Peng, H. Eugene Stanley, Ary L. Goldberger, Emma Gordon, Lena Claesson‐Welsh, Roger J. Laham, Robert Rosenberg and J. Anthony Ware and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Michael Simons

425 papers receiving 33.7k citations

Hit Papers

Mosaic organization of DNA nucleotides 1992 2026 2003 2014 1994 2016 1992 1992 2002 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mosaic organization of DNA nucleotides
    1994 3.9k citations Michael Simons et al. profile →
  2. Mechanisms and regulation of endothelial VEGF receptor signalling
    2016 1.1k citations Michael Simons et al. profile →
  3. Long-range correlations in nucleotide sequences
    1992 1.1k citations Michael Simons et al. profile →
  4. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
    1992 582 citations Michael Simons, Robert Rosenberg et al. profile →
  5. Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2
    2002 512 citations Michael Simons, Roger J. Laham et al. Circulation profile →
  6. Endothelial Cell Metabolism in Normal and Diseased Vasculature
    2015 497 citations Michael Simons, Peter Carmeliet et al. Circulation Research profile →
  7. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis
    2013 482 citations Michael Simons et al. profile →
  8. Endothelial-to-mesenchymal transition drives atherosclerosis progression
    2015 417 citations Pei‐Yu Chen, Lingfeng Qin et al. Journal of Clinical Investigation profile →
  9. Endothelial-Derived Angiocrine Signals Induce and Sustain Regenerative Lung Alveolarization
    2011 382 citations Michael Simons et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Simons United States 97 18.7k 5.9k 4.2k 4.1k 4.0k 432 34.6k
J. Jack Lee United States 111 17.2k 0.9× 6.5k 1.1× 1.0k 0.2× 7.5k 1.8× 928 0.2× 1.1k 50.3k
James R. Wright Canada 98 13.4k 0.7× 4.0k 0.7× 500 0.1× 3.9k 0.9× 979 0.2× 1.0k 39.1k
Larry Norton United States 98 13.7k 0.7× 2.9k 0.5× 715 0.2× 16.0k 3.9× 1.6k 0.4× 532 50.7k
Richard Simon United States 92 8.4k 0.5× 2.7k 0.5× 2.0k 0.5× 5.2k 1.3× 1.1k 0.3× 352 35.9k
Leroy Hood United States 140 43.1k 2.3× 2.5k 0.4× 255 0.1× 5.8k 1.4× 908 0.2× 730 75.8k
Michele Pagano United States 104 28.0k 1.5× 2.2k 0.4× 422 0.1× 3.9k 1.0× 466 0.1× 460 42.8k
David W. Russell United States 126 29.5k 1.6× 12.4k 2.1× 123 0.0× 4.7k 1.2× 1.6k 0.4× 542 52.6k
John F. Thompson Australia 93 15.6k 0.8× 3.7k 0.6× 446 0.1× 4.1k 1.0× 361 0.1× 1.0k 46.5k
David R. Jones United States 74 4.4k 0.2× 5.1k 0.9× 966 0.2× 1.8k 0.4× 3.4k 0.9× 643 29.1k
Kenneth R. Hess United States 98 9.9k 0.5× 6.4k 1.1× 257 0.1× 8.5k 2.1× 3.2k 0.8× 509 41.8k

Countries citing papers authored by Michael Simons

Since Specialization
Citations

This map shows the geographic impact of Michael Simons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Simons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Simons more than expected).

Fields of papers citing papers by Michael Simons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Simons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Simons. The network helps show where Michael Simons may publish in the future.

Co-authorship network of co-authors of Michael Simons

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Simons. A scholar is included among the top collaborators of Michael Simons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Simons. Michael Simons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simons, Michael. (2023). Endothelial-to-mesenchymal transition: advances and controversies. Current Opinion in Physiology. 34. 100678–100678. 3 indexed citations
2.
Boutagy, Nabil E., Joseph W. Fowler, Kariona A. Grabińska, et al.. (2023). TNFα increases the degradation of pyruvate dehydrogenase kinase 4 by the Lon protease to support proinflammatory genes. Proceedings of the National Academy of Sciences. 120(38). e2218150120–e2218150120. 10 indexed citations
3.
Corti, Federico, Emma Ristori, Félix Rivera-Molina, et al.. (2022). Syndecan-2 selectively regulates VEGF-induced vascular permeability. Nature Cardiovascular Research. 1(5). 518–528. 17 indexed citations
4.
Min, Elizabeth, Nicolas Baeyens, Brian G. Coon, et al.. (2021). Activation of Smad2/3 signaling by low fluid shear stress mediates artery inward remodeling. Proceedings of the National Academy of Sciences. 118(37). 48 indexed citations
5.
Corti, Federico, Yingdi Wang, John Rhodes, et al.. (2019). N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA165-dependent neovascularization. Nature Communications. 10(1). 1562–1562. 61 indexed citations
6.
Zhang, Feng, Georgia Zarkada, Jinah Han, et al.. (2018). Lacteal junction zippering protects against diet-induced obesity. Science. 361(6402). 599–603. 166 indexed citations
7.
Chen, Pei‐Yu, Lingfeng Qin, Nicolas Baeyens, et al.. (2015). Endothelial-to-mesenchymal transition drives atherosclerosis progression. Journal of Clinical Investigation. 125(12). 4514–4528. 417 indexed citations breakdown →
8.
Zhang, Xi & Michael Simons. (2014). Receptor Tyrosine Kinases Endocytosis in Endothelium. Arteriosclerosis Thrombosis and Vascular Biology. 34(9). 1831–1837. 26 indexed citations
9.
Gabhann, Feilim Mac, et al.. (2013). Endothelial Cell–Dependent Regulation of Arteriogenesis. Circulation Research. 113(9). 1076–1086. 52 indexed citations
10.
Tı̂rziu, Daniela, Irina M. Jaba, Pengchun Yu, et al.. (2012). Endothelial Nuclear Factor-κB–Dependent Regulation of Arteriogenesis and Branching. Circulation. 126(22). 2589–2600. 56 indexed citations
11.
Mulligan‐Kehoe, Mary Jo & Michael Simons. (2007). Current concepts in normal and defective angiogenesis: Implications for systemic sclerosis. Current Rheumatology Reports. 9(2). 173–179. 17 indexed citations
12.
Tkachenko, Eugene, Esther Lutgens, Radu V. Stan, & Michael Simons. (2004). Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway. Journal of Cell Science. 117(15). 3189–3199. 115 indexed citations
13.
Li, Jian, Jianyi Li, Thomas Hampton, et al.. (2002). Modulation of Microvascular Signaling by Heparan Sulfate Matrix: Studies in Syndecan-4 Transgenic Mice. Microvascular Research. 64(1). 38–46. 20 indexed citations
14.
Ruel, Marc, Roger J. Laham, Mark J. Post, et al.. (2002). Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. Journal of Thoracic and Cardiovascular Surgery. 124(1). 28–34. 117 indexed citations
15.
Hendel, Robert C., Timothy D. Henry, Krishna J. Rocha‐Singh, et al.. (2000). Effect of Intracoronary Recombinant Human Vascular Endothelial Growth Factor on Myocardial Perfusion. Circulation. 101(2). 118–121. 225 indexed citations
16.
Li, Jian, Mark J. Post, Youhe Gao, et al.. (2000). PR39, a peptide regulator of angiogenesis. Nature Medicine. 6(1). 49–55. 303 indexed citations
17.
Sellke, Frank W., Motohisa Tofukuji, Roger J. Laham, et al.. (1998). Comparison of VEGF Delivery Techniques on Collateral-Dependent Microvascular Reactivity. Microvascular Research. 55(2). 175–178. 19 indexed citations
18.
Li, Jason, Thomas Hampton, James P. Morgan, & Michael Simons. (1997). Stretch-induced VEGF expression in the heart.. Journal of Clinical Investigation. 100(1). 18–24. 150 indexed citations
19.
Simons, Michael, et al.. (1994). DPB1 LOCUS PCR‐RFLP TYPING OF THE FOURTH ASIA‐OCEANIA HISTOCOMPATIBILITY WORKSHOP CELL PANEL REVEALS A NOVEL DPB1 ALLELE. International Journal of Immunogenetics. 21(5). 351–364. 4 indexed citations
20.
Harada, Kazumasa, William Grossman, M. Friedman, et al.. (1994). Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.. Journal of Clinical Investigation. 94(2). 623–630. 234 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Jack Lee Breakdown of academic impact, for papers by James R. Wright Breakdown of academic impact, for papers by Larry Norton Breakdown of academic impact, for papers by Richard Simon Breakdown of academic impact, for papers by Leroy Hood Breakdown of academic impact, for papers by Michele Pagano Breakdown of academic impact, for papers by David W. Russell Breakdown of academic impact, for papers by John F. Thompson Breakdown of academic impact, for papers by David R. Jones Breakdown of academic impact, for papers by Kenneth R. Hess
Rankless by CCL
2026